Skip to Main content Skip to Navigation
Journal articles

Therapy: Metformin takes a new route to clinical efficacy.

Abstract : Metformin is currently the first-line treatment option for patients with type 2 diabetes mellitus, yet its mechanism of action remains uncertain. A new study reveals the important role for the activation of a duodenal AMPK-dependent neuronal pathway in the acute antihyperglycaemic effect of metformin and the inhibition of hepatic glucose production.
Document type :
Journal articles
Complete list of metadata

Cited literature [10 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-01171783
Contributor : Benoit Viollet Connect in order to contact the contributor
Submitted on : Monday, July 6, 2015 - 12:32:26 PM
Last modification on : Tuesday, October 19, 2021 - 11:57:42 PM
Long-term archiving on: : Tuesday, April 25, 2017 - 11:56:28 PM

Files

NRE_[Viollet]_revised_HAL-1.pd...
Files produced by the author(s)

Identifiers

Collections

Citation

Marc Foretz, Benoit Viollet. Therapy: Metformin takes a new route to clinical efficacy.. Nature Reviews Endocrinology, Nature Publishing Group, 2015, nature reviews endocrinology, 11 (7), pp.390-392. ⟨inserm-01171783⟩

Share

Metrics

Record views

266

Files downloads

580